Inhibitory effect of terfenadine on Kir2.1 and Kir2.3 channels
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Terfenadine is a second-generation H1-antihistamine that despite potentially can produce severe side effects it has recently gained attention due to its anticancer properties. Lately, the subfamily 2 of inward rectifier potassium channels (Kir2) has been implicated in the progression of some tumoral processes. Hence, we characterized the effects of terfenadine on Kir2.x channels expressed in HEK-293 cells. Terfenadine inhibited Kir2.3 channels with a strikingly greater potency (IC50 = 1.06 ± 0.11 μmol L–1) compared to Kir2.1 channels (IC50 = 27.8 ± 4.8 μmol L–1). The Kir2.3(I213L) mutant, possessing a larger affinity for phosphatidylinositol 4,5-bisphosphate (PIP2) than the wild-type Kir2.3, was less sensitive to terfenadine inhibition (IC50 = 13.0 ± 2.9 μmol L–1). Additionally, the PIP2 intracellular application had largely reduced the inhibition of Kir2.1 channels by terfenadine. Our data support that Kir2.x channels are targets of terfenadine by affecting their interaction with PIP2, which could be regarded as a mechanism of the antitumor properties of terfenadine. © 2021 Sciendo. All rights reserved.
publication date
funding provided via
published in
Research
keywords
-
5-bisphosphate; Cationic amphiphilic drugs; Inward rectifier potassium channels; Phosphatidylinositol 4; Terfenadine amino acid; complementary DNA; green fluorescent protein; membrane receptor; phosphatidylinositol; phosphatidylinositol 4,5 bisphosphate; sodium channel Nav1.5; terfenadine; antineoplastic activity; Article; binding site; biophysics; blood vessel reactivity; cell invasion; cell migration; channel gating; channel interaction; chemical structure; controlled study; DNA sequencing; drug structure; electrophysiology; gene expression; gene mutation; genetic transfection; human; human cell; IC50; perfusion; protein expression; protein function; structure activity relation
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue